Associations between three common microRNA polymorphisms and hepatocellular carcinoma risk in Chinese

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6601-6604

  Hao, Yu Xia ^a   Wang, Jun Ping ^b   Zhao, Long Feng ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

HBV; Hepatocellular carcinoma; MicroRNA; Polymorphisms; Risk

Indexed keywords

EID: 84892458032     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6601     Document Type: Article

References (32)

1. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
2. Davila JA, Morgan RO, Shaib Y, et al (2004). Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology, 127, 1372-80.
3. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76.
4. Esquela-Kerscher A, Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.
5. Han Y, Pu R, Han X, et al (2013). Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One, 8, e58564.
6. Hu M, Zhao L, Hu S, Yang J (2013). The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population. PLoS One, 8, e57012.
7. Huang S, He X (2011). The role of microRNAs in liver cancer progression. Br J Cancer, 104, 235-40.
8. International Agency for Research on Cancer (2008). Globocan 2008 in China. http://globocan.iarc.fr/factsheet.asp.
9. Jang MJ, Kim JW, Min KT, et al (2011). Prognostic significance of microRNA gene polymorphisms in patients with surgically resected colorectal cancer. Exp Ther Med, 2, 1127-32.
10. Kim WH, Min KT, Jeon YJ, et al (2012). Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene, 504, 92-7.
11. Li XD, Li ZG, Song XX, Liu CF (2010). A variant in microRNA- 196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology, 42, 669-73.
12. Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73.
13. Linhares JJ, Azevedo M Jr, SiufiAA, et al (2012). Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR- 196a2 rs11614913 C/T) from Brazilian women with breast cancer. BMC Med Genet, 13, 119.
14. Ladeiro Y, Couchy G, Balabaud C, et al (2008). MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47, 1955-63.
15. Li W, Xie L, He X, et al (2008). Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer, 123, 1616-22.
16. Masaki T (2009). MicroRNA and hepatocellular carcinoma. Hepatol Res, 39,751-2.
17. Pavlakis E, Papaconstantinou I, Gazouli M, et al (2013). MicroRNA gene polymorphisms in pancreatic cancer. Pancreatology, 13, 273-8.
18. Qi P, Dou TH, Geng L, et al (2010). Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol, 71, 621-6.
19. Valencia-Sanchez MA, Liu J, Hannon GJ, et al (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev, 20, 515-24.
20. Vinci S, Gelmini S, Pratesi N, et al (2011). Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med, 49, 2073-80.
21. Wang F, Sun GP, Zou YF, et al (2013). Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and gastrointestinal cancer risk. Mol Biol Rep, 40, 109-16.
22. Wang PY, Gao ZH, Jiang ZH, et al (2013). The Associations of Single Nucleotide Polymorphisms in miR-146a, miR-196a and miR-499 with Breast Cancer Susceptibility. PLoS One, 8, e70656.
23. Wei J, Zheng L, Liu S, et al (2013). MiR-196a2 rs11614913 T>C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol, 74, 1199-205.
24. Wilfred BR, Wang WX, Nelson PT (2007). Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab, 91, 209-17.
25. Wu M, Jolicoeur N, Li Z, et al (2008). Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis, 29, 1710-6.
26. Wu XJ, Mi YY, Yang H, et al (2013). Association of the hsa-mir-499 (rs3746444) Polymorphisms with Gastric Cancer Risk in the Chinese Population. Onkologie, 36, 573-6.
27. Xiang Y, Fan S, Cao J, et al (2012). Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep, 39, 7019-23.
28. Yuan Z, Zeng X, Yang D, Wang W, Liu Z (2013). Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk. PLoS One, 8, e61047.
29. Yu MC, Yuan JM (2004). Environmental factors and risk for hepatocellular carcinoma. Gastroenterology, 127, S72-8.
30. Zhan X, Wu W, Han B, et al (2012). Hsa-miR-196a2 functional SNP is associated with severe toxicity after platinum-based chemotherapy of advanced nonsmall cell lung cancer patients in a Chinese population. J Clin Lab Anal, 26, 441-6.
31. Zhang YG, Shi JX, Song CH, et al (2013). Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies. Asian Pac J Cancer Prev, 14, 2337-42.
32. Zheng SQ, Li YX, Zhang Y, Li X, Tang H (2011). MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res, 89, 219-26.